Proactive Investors - Run By Investors For Investors

MMJ Phytotech invests into major Canadian medical cannabis company

The C$5 million investment gives MMJ a 6.9% interest in MediPharm Labs Inc.
Cannabis growing facility
MMJ has a diversified portfolio of cannabis sector investments

MMJ PhytoTech Ltd (ASX:MMJ) has invested C$5 million for a 6.9% basic shareholding in MediPharm Labs Inc, which owns Canada’s largest medical cannabis oil production facility.

MMJ is a global cannabis investment company with a diversified portfolio of cannabis sector investments.

READ: MMJ PhytoTech invests into global cannabis lifestyle brand

It has made a number of recent investments with Ontario-based MediPharm Labs representing the ninth.

As well as the production facility supporting 100,000 kilograms of annual dry cannabis processing, MediPharm owns a majority share in MediPharm Labs Australia.

Australian operation

This operation, which is based in Wonthaggi, Victoria, has lodged a cannabis manufacturing licence application.

MMJ’s CEO Jason Conroy said: “As Canada’s largest medical cannabis oil production facility and with a strategic presence in Australia, MediPharm is strongly positioned to capitalise on growth opportunities in Canada and overseas.”

ACMPR licensed producer

MediPharm is an Access to Cannabis for Medical Purposes Regulations (ACMPR) licensed producer for the production of cannabis oil and expects to receive a sales licence later this year.

It uses innovative extraction technologies that create products designed for specific patient solutions and has manufacturing and distribution partnerships with proven patented formulators.

MediPharm is strongly positioned to capitalise on Canadian medical cannabis oil market sales growth, both for domestic patients and for export.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full MMJ profile View Profile

MMJ Group Holdings Ltd Timeline

Related Articles

cannabis on dollar bills
June 09 2019
Australis invests in the highly fragmented, rapidly evolving US cannabis space, with a focus on building companies through early-stage, diversified and opportunistic investments
November 03 2018
Back Home Medical Cannabis Corp has agreed on a 24,000-kilogram three-year production and supply agreement
medicinal cannabis concept
January 31 2019
Zelda has released its December quarterly report confirming multiple trials are on track.

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use